Obesity, insulin resistance and diabetes: Sex differences and role of oestrogen receptors

Acta Physiologica

Volumn 203, Issue 1, 2011, Pages 259-269

  Meyer, M R ^a,b   Clegg, D J ^c   Prossnitz, E R ^d   Barton, M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Adipocyte; Aromatase; Atherosclerosis; Myocardial infarction; Oestradiol; Visceral fat

Indexed keywords

AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; GLUCOSE; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ABDOMINAL OBESITY; ADIPOCYTE; ADIPOSE TISSUE; AGING; AROMATIZATION; BODY FAT; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CATALYSIS; CELL COUNT; DIABETES MELLITUS; DISEASE ASSOCIATION; ENERGY BALANCE; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; FATTY ACID OXIDATION; GENE MUTATION; GENETIC POLYMORPHISM; GLUCOSE INTOLERANCE; HOMEOSTASIS; HORMONE ACTION; HORMONE METABOLISM; HUMAN; HYPERINSULINEMIA; HYPOGONADISM; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MENOPAUSE; MENSTRUAL CYCLE; METABOLIC INHIBITION; NONHUMAN; OBESITY; OVARY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; REVIEW; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; UNITED STATES; WEIGHT CONTROL;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ESTROGENS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; RECEPTORS, ESTROGEN; SEX CHARACTERISTICS;

EID: 80051668223     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2010.02237.x     Document Type: Review

References (125)

1. Ahmed-Sorour, H. & Bailey, C.J. 1981. Role of ovarian hormones in the long-term control of glucose homeostasis, glycogen formation and gluconeogenesis. Ann Nutr Metab 25, 208-212.
2. Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T.I., Prossnitz, E.R., Musti, A.M., Ando, S. & Maggiolini, M. 2007. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67, 1859-1866.
3. Alisi, A., Locatelli, M. & Nobili, V. 2010. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 13, 397-402.
4. Alonso-Magdalena, P., Ropero, A.B., Carrera, M.P., Cederroth, C.R., Baquie, M., Gauthier, B.R., Nef, S., Stefani, E. & Nadal, A. 2008. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 3, e2069.
5. Andrade, H., Antonio, N., Rodrigues, D., Da Silva, M., Pego, M. & Providencia, L.A. 2010. High blood pressure in the pediatric age group. Rev Port Cardiol 29, 413-432.
6. Arnlov, J., Ingelsson, E., Sundstrom, J. & Lind, L. 2010. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121, 230-236.
7. Asarian, L. & Geary, N. 1999. Cyclic estradiol treatment phasically potentiates endogenous cholecystokinin's satiating action in ovariectomized rats. Peptides 20, 445-450.
8. Baglietto, L., English, D.R., Hopper, J.L., MacInnis, R.J., Morris, H.A., Tilley, W.D., Krishnan, K. & Giles, G.G. 2009. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Res Treat 115, 171-179.
9. Bailey, C.J. & Ahmed-Sorour, H. 1980. Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. Diabetologia 19, 475-481.
10. Balhuizen, A., Kumar, R., Amisten, S., Lundquist, I. & Salehi, A. 2010. Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice. Mol Cell Endocrinol 320, 16-24.
11. Bandyopadhyay, G.K., Yu, J.G., Ofrecio, J. & Olefsky, J.M. 2006. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277-2285.
12. Baptista, T., de Baptista, E.A., Hernandez, L., Altemus, M. & Weiss, S.R. 1997. Tamoxifen prevents sulpiride-induced weight gain in female rats. Pharmacol Biochem Behav 57, 215-222.
13. Barros, R.P., Machado, U.F., Warner, M. & Gustafsson, J.A. 2006. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci USA 103, 1605-1608.
14. Barton, M. 2010. Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch 460, 825-837.
15. Barton, M. & Furrer, J. 2003. Cardiovascular consequences of the obesity pandemic: need for action. Expert Opin Investig Drugs 12, 1757-1759.
16. Barton, M. & Meyer, M.R. 2009. Postmenopausal hypertension: mechanisms and therapy. Hypertension 54, 11-18.
17. Barton, M., Carmona, R., Morawietz, H., d'Uscio, L.V., Goettsch, W., Hillen, H., Haudenschild, C.C., Krieger, J.E., Munter, K., Lattmann, T., Luscher, T.F. & Shaw, S. 2000. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 35, 329-336.
18. Barton, M., Carmona, R., Ortmann, J., Krieger, J.E. & Traupe, T. 2003. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochem Cell Biol 35, 826-837.
19. Belcher, B.R., Berrigan, D., Dodd, K.W., Emken, B.A., Chou, C.P. & Spuijt-Metz, D. 2010. Physical activity in US youth: effect of race/ethnicity, age, gender, & weight status. Med Sci Sports Exerc 42, 2211-2221.
20. Blasko, E., Haskell, C.A., Leung, S., Gualtieri, G., Halks-Miller, M., Mahmoudi, M., Dennis, M.K., Prossnitz, E.R., Karpus, W.J. & Horuk, R. 2009. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 214, 67-77.
21. Bologa, C.G., Revankar, C.M., Young, S.M., Edwards, B.S., Arterburn, J.B., Kiselyov, A.S., Parker, M.A., Tkachenko, S.E., Savchuck, N.P., Sklar, L.A., Oprea, T.I. & Prossnitz, E.R. 2006. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2, 207-212.
22. Bramlage, P., Pittrow, D., Wittchen, H.U., Kirch, W., Boehler, S., Lehnert, H., Hoefler, M., Unger, T. & Sharma, A.M. 2004. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 17, 904-910.
23. Brinton, L.A., Carreon, J.D., Gierach, G.L., McGlynn, K.A. & Gridley, G. 2010. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat 119, 185-192.
24. Brown, L.M. & Clegg, D.J. 2010. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 122, 65-73.
25. Brown, L.M., Gent, L., Davis, K. & Clegg, D.J. 2010. Metabolic impact of sex hormones on obesity. Brain Res 1350, 77-85.
26. Brussaard, H.E., Gevers Leuven, J.A., Frolich, M., Kluft, C. & Krans, H.M. 1997. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40, 843-849.
27. Bryzgalova, G., Gao, H., Ahren, B., Zierath, J.R., Galuska, D., Steiler, T.L., Dahlman-Wright, K., Nilsson, S., Gustafsson, J.A., Efendic, S. & Khan, A. 2006. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49, 588-597.
28. Canonaco, M., Giusi, G., Madeo, A., Facciolo, R.M., Lappano, R., Canonaco, A. & Maggiolini, M. 2008. A sexually dimorphic distribution pattern of the novel estrogen receptor G-protein-coupled receptor 30 in some brain areas of the hamster. J Endocrinol 196, 131-138.
29. Chen, M.Y., Chou, C.C. & Yang, R.J. 2005. Considering the factors of gender and body weight in the promotion of healthy behavior among adolescents. J Nurs Res 13, 235-243.
30. Chow, R.W., Handelsman, D.J. & Ng, M.K. 2010. Minireview: rapid actions of sex steroids in the endothelium. Endocrinology 151, 2411-2422.
31. Cignarella, A., Bolego, C., Pelosi, V., Meda, C., Krust, A., Pinna, C., Gaion, R.M., Vegeto, E. & Maggi, A. 2009. Distinct roles of estrogen receptor-alpha and beta in the modulation of vascular inducible nitric-oxide synthase in diabetes. J Pharmacol Exp Ther 328, 174-182.
32. Cleland, W.H., Mendelson, C.R. & Simpson, E.R. 1985. Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab 60, 174-177.
33. Deng, H.W., Li, J., Li, J.L., Dowd, R., Davies, K.M., Johnson, M., Gong, G., Deng, H. & Recker, R.R. 2000. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 85, 2748-2751.
34. Dennis, M.K., Burai, R., Ramesh, C., Petrie, W.K., Alcon, S.N., Nayak, T.K., Bologa, C.G., Leitao, A., Brailoiu, E., Deliu, E. et al. 2009. In vivo effects of a GPR30 antagonist. Nat Chem Biol 5, 421-427.
35. Denzer, C., Thiere, D., Muche, R., Koenig, W., Mayer, H., Kratzer, W. & Wabitsch, M. 2009. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 94, 3872-3881.
36. Dieudonne, M.N., Leneveu, M.C., Giudicelli, Y. & Pecquery, R. 2004. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 286, C655-C661.
37. Enzi, G., Gasparo, M., Biondetti, P.R., Fiore, D., Semisa, M. & Zurlo, F. 1986. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 44, 739-746.
38. Evans, M.J., Eckert, A., Lai, K., Adelman, S.J. & Harnish, D.C. 2001. Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res 89, 823-830.
39. Evans, M.J., Lai, K., Shaw, L.J., Harnish, D.C. & Chadwick, C.C. 2002. Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver. Endocrinology 143, 2559-2570.
40. Filardo, E.J., Quinn, J.A., Bland, K.I. & Frackelton, A.R., Jr 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14, 1649-1660.
41. Ford, J., Hajibeigi, A., Long, M., Hahner, L., Gore, C., Hsieh, J.T., Clegg, D., Zerwekh, J. & Oz, O.K. 2010. GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice. J Bone Miner Res: DOI: 10.1002/jbmr.209.
42. Foryst-Ludwig, A., Clemenz, M., Hohmann, S., Hartge, M., Sprang, C., Frost, N., Krikov, M., Bhanot, S., Barros, R., Morani, A., Gustafsson, J.A., Unger, T. & Kintscher, U. 2008. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet 4, e1000108.
43. Fox, C.S., Yang, Q., Cupples, L.A., Guo, C.Y., Atwood, L.D., Murabito, J.M., Levy, D., Mendelsohn, M.E., Housman, D.E. & Shearman, A.M. 2005. Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: the Framingham Heart Study. J Clin Endocrinol Metab 90, 6257-6262.
44. French, S.A., Story, M. & Jeffery, R.W. 2001. Environmental influences on eating and physical activity. Annu Rev Public Health 22, 309-335.
45. Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U. & Pasquali, R. 2002. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26, 883-896.
46. Geer, E.B. & Shen, W. 2009. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6(Suppl. 1), 60-75.
47. Goulart, A.C., Zee, R.Y. & Rexrode, K.M. 2009. Association of estrogen receptor 2 gene polymorphisms with obesity in women (obesity and estrogen receptor 2 gene). Maturitas 62, 179-183.
48. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.M., Argos, P. & Chambon, P. 1986. Human oestrogen receptor cDNA: sequence, expression and homology to v- erb-A. Nature 320, 134-139.
49. Greene, G.L., Gilna, P., Waterfield, M., Baker, A., Hort, Y. & Shine, J. 1986. Sequence and expression of human estrogen receptor complementary DNA. Science 231, 1150-1154.
50. Gruber, C.J., Tschugguel, W., Schneeberger, C. & Huber, J.C. 2002. Production and actions of estrogens. N Engl J Med 346, 340-352.
51. Haas, E., Bhattacharya, I., Brailoiu, E., Damjanovic, M., Brailoiu, G.C., Gao, X., Mueller-Guerre, L., Marjon, N.A., Gut, A., Minotti, R. et al. 2009. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104, 288-291.
52. Haffner, S.M., Katz, M.S. & Dunn, J.F. 1991. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes 15, 471-478.
53. Hammes, S.R. & Levin, E.R. 2007. Extranuclear steroid receptors: nature and actions. Endocr Rev 28, 726-741.
54. Harvie, M., Howell, A., Vierkant, R.A., Kumar, N., Cerhan, J.R., Kelemen, L.E., Folsom, A.R. & Sellers, T.A. 2005. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 14, 656-661.
55. Heine, P.A., Taylor, J.A., Iwamoto, G.A., Lubahn, D.B. & Cooke, P.S. 2000. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97, 12729-12734.
56. Hugo, E.R., Brandebourg, T.D., Woo, J.G., Loftus, J., Alexander, J.W. & Ben-Jonathan, N. 2008. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 116, 1642-1647.
57. Isensee, J., Meoli, L., Zazzu, V., Nabzdyk, C., Witt, H., Soewarto, D., Effertz, K., Fuchs, H., Gailus-Durner, V., Busch, D., Adler, T., de Angelis, M.H., Irgang, M., Otto, C. & Noppinger, P.R. 2009. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 150, 1722-1730.
58. James, W.P. 2008. The epidemiology of obesity: the size of the problem. J Intern Med 263, 336-352.
59. Jones, M.E., Thorburn, A.W., Britt, K.L., Hewitt, K.N., Wreford, N.G., Proietto, J., Oz, O.K., Leury, B.J., Robertson, K.M., Yao, S. & Simpson, E.R. 2000. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97, 12735-12740.
60. Kanda, N. & Watanabe, S. 2003. 17Beta-estradiol enhances the production of nerve growth factor in THP-1-derived macrophages or peripheral blood monocyte-derived macrophages. J Invest Dermatol 121, 771-780.
61. Kannel, W.B., Cupples, L.A., Ramaswami, R., Stokes, J., 3rd, Kreger, B.E. & Higgins, M. 1991. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 44, 183-190.
62. Kaye, S.A., Folsom, A.R., Soler, J.T., Prineas, R.J. & Potter, J.D. 1991. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 20, 151-156.
63. Kuiper, G.G., Enmark, E., Pelto-Huikko, M., Nilsson, S. & Gustafsson, J.A. 1996. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93, 5925-5930.
64. Langer, G., Bader, B., Meoli, L., Isensee, J., Delbeck, M., Noppinger, P.R. & Otto, C. 2010. A critical review of fundamental controversies in the field of GPR30 research. Steroids 75, 603-610.
65. Le May, C., Chu, K., Hu, M., Ortega, C.S., Simpson, E.R., Korach, K.S., Tsai, M.J. & Mauvais-Jarvis, F. 2006. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103, 9232-9237.
66. Liang, Y.Q., Akishita, M., Kim, S., Ako, J., Hashimoto, M., Iijima, K., Ohike, Y., Watanabe, T., Sudoh, N., Toba, K., Yoshizumi, M. & Ouchi, Y. 2002. Estrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord 26, 1103-1109.
67. Lin, B.C., Suzawa, M., Blind, R.D., Tobias, S.C., Bulun, S.E., Scanlan, T.S. & Ingraham, H.A. 2009. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res 69, 5415-5423.
68. Liu, S. & Mauvais-Jarvis, F. 2009. Rapid, nongenomic estrogen actions protect pancreatic islet survival. Islets 1, 273-275.
69. Liu, S., Le May, C., Wong, W.P., Ward, R.D., Clegg, D.J., Marcelli, M., Korach, K.S. & Mauvais-Jarvis, F. 2009. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58, 2292-2302.
70. Ludwig, D.S. 2007. Childhood obesity - the shape of things to come. N Engl J Med 357, 2325-2327.
71. Maffei, L., Murata, Y., Rochira, V., Tubert, G., Aranda, C., Vazquez, M., Clyne, C.D., Davis, S., Simpson, E.R. & Carani, C. 2004. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89, 61-70.
72. Maffei, L., Rochira, V., Zirilli, L., Antunez, P., Aranda, C., Fabre, B., Simone, M.L., Pignatti, E., Simpson, E.R., Houssami, S., Clyne, C.D. & Carani, C. 2007. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol (Oxf) 67, 218-224.
73. Martensson, U.E., Salehi, S.A., Windahl, S., Gomez, M.F., Sward, K., Daszkiewicz-Nilsson, J., Wendt, A., Andersson, N., Hellstrand, P., Grande, P.O. et al. 2009. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150, 687-698.
74. Matthews, J. & Gustafsson, J.A. 2003. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 3, 281-292.
75. Meli, R., Pacilio, M., Raso, G.M., Esposito, E., Coppola, A., Nasti, A., Di Carlo, C., Nappi, C. & Di Carlo, R. 2004. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145, 3115-3121.
76. Meyer, M.R., Haas, E. & Barton, M. 2006. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension 47, 1019-1026.
77. Meyer, M.R., Haas, E., Prossnitz, E.R. & Barton, M. 2009. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol 308, 9-16.
78. Meyer, M.R., Baretella, O., Prossnitz, E.R. & Barton, M. 2010. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182, 780. Pharmacology 86, 58-64.
79. Misso, M.L., Murata, Y., Boon, W.C., Jones, M.E., Britt, K.L. & Simpson, E.R. 2003. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 144, 1474-1480.
80. Mokdad, A.H., Ford, E.S., Bowman, B.A., Dietz, W.H., Vinicor, F., Bales, V.S. & Marks, J.S. 2003. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76-79.
81. Morishima, A., Grumbach, M.M., Simpson, E.R., Fisher, C. & Qin, K. 1995. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80, 3689-3698.
82. Mundy, A.L., Haas, E., Bhattacharya, I., Widmer, C.C., Kretz, M., Hofmann-Lehmann, R., Minotti, R. & Barton, M. 2007. Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res 73, 368-375.
83. Musatov, S., Chen, W., Pfaff, D.W., Mobbs, C.V., Yang, X.J., Clegg, D.J., Kaplitt, M.G. & Ogawa, S. 2007. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA 104, 2501-2506.
84. Naaz, A., Zakroczymski, M., Heine, P., Taylor, J., Saunders, P., Lubahn, D. & Cooke, P.S. 2002. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res 34, 758-763.
85. Nadal, A., Alonso-Magdalena, P., Soriano, S., Ropero, A.B. & Quesada, I. 2009. The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 587, 5031-5037.
86. Nilsson, M., Dahlman, I., Ryden, M., Nordstrom, E.A., Gustafsson, J.A., Arner, P. & Dahlman-Wright, K. 2007. Oestrogen receptor alpha gene expression levels are reduced in obese compared to normal weight females. Int J Obes (Lond) 31, 900-907.
87. Noel, S.D., Keen, K.L., Baumann, D.I., Filardo, E.J. & Terasawa, E. 2009. Involvement of G protein-coupled receptor 30 (GPR30) in rapid action of estrogen in primate LHRH neurons. Mol Endocrinol 23, 349-359.
88. Ogden, C.L., Yanovski, S.Z., Carroll, M.D. & Flegal, K.M. 2007. The epidemiology of obesity. Gastroenterology 132, 2087-2102.
89. Ohlsson, C., Hellberg, N., Parini, P., Vidal, O., Bohlooly, M., Rudling, M., Lindberg, M.K., Warner, M., Angelin, B. & Gustafsson, J.A. 2000. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 278, 640-645.
90. Okura, T., Koda, M., Ando, F., Niino, N., Ohta, S. & Shimokata, H. 2003. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord 27, 1020-1027.
91. Olde, B. & Leeb-Lundberg, L.M. 2009. GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab 20, 409-416.
92. Olshansky, S.J., Passaro, D.J., Hershow, R.C., Layden, J., Carnes, B.A., Brody, J., Hayflick, L., Butler, R.N., Allison, D.B. & Ludwig, D.S. 2005. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352, 1138-1145.
93. Pedersen, S.B., Borglum, J.D., Moller-Pedersen, T. & Richelsen, B. 1992. Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol Cell Endocrinol 85, 13-19.
94. Prossnitz, E.R. & Barton, M. 2009. Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat 89, 89-97.
95. Prossnitz, E.R., Arterburn, J.B. & Sklar, L.A. 2007. GPR30: a G protein-coupled receptor for estrogen. Mol Cell Endocrinol 265-266, 138-142.
96. Prossnitz, E.R., Arterburn, J.B., Smith, H.O., Oprea, T.I., Sklar, L.A. & Hathaway, H.J. 2008. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70, 165-190.
97. Rettew, J.A., McCall, S.H.t. & Marriott, I. 2010. GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Mol Cell Endocrinol 328, 87-92.
98. Revankar, C.M., Cimino, D.F., Sklar, L.A., Arterburn, J.B. & Prossnitz, E.R. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630.
99. Ribas, V., Nguyen, M.T., Henstridge, D.C., Nguyen, A.K., Beaven, S.W., Watt, M.J. & Hevener, A.L. 2010. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ER{alpha} deficient mice. Am J Physiol Endocrinol Metab 298, E304-E319.
100. Ridker, P.M., Brown, N.J., Vaughan, D.E., Harrison, D.G. & Mehta, J.L. 2004. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109, IV6-IV19.
101. Rinaldi, S., Key, T.J., Peeters, P.H., Lahmann, P.H., Lukanova, A., Dossus, L., Biessy, C., Vineis, P., Sacerdote, C., Berrino, F. et al. 2006. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer 118, 2832-2839.
102. Ryder, J.W., Gilbert, M. & Zierath, J.R. 2001. Skeletal muscle and insulin sensitivity: pathophysiological alterations. Front Biosci 6, D154-D163.
103. Saltiki, K., Mantzou, E., Doukas, C., Kanakakis, I., Zotos, P., Lazaros, L., Georgiou, I. & Alevizaki, M. 2009. Estrogen receptor beta gene variants may be associated with more favorable metabolic profile in postmenopausal women undergoing coronary angiography. Exp Clin Endocrinol Diabetes 117, 610-615.
104. Samuel, V.T., Petersen, K.F. & Shulman, G.I. 2010. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375, 2267-2277.
105. Schneider, G., Kirschner, M.A., Berkowitz, R. & Ertel, N.H. 1979. Increased estrogen production in obese men. J Clin Endocrinol Metab 48, 633-638.
106. Shi, H. & Clegg, D.J. 2009. Sex differences in the regulation of body weight. Physiol Behav 97, 199-204.
107. Siiteri, P.K. 1987. Adipose tissue as a source of hormones. Am J Clin Nutr 45, 277-282.
108. Smith, E.P., Boyd, J., Frank, G.R., Takahashi, H., Cohen, R.M., Specker, B., Williams, T.C., Lubahn, D.B. & Korach, K.S. 1994. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331, 1056-1061.
109. Sorof, J. & Daniels, S. 2002. Obesity hypertension in children: a problem of epidemic proportions. Hypertension 40, 441-447.
110. Stewart, S.T., Cutler, D.M. & Rosen, A.B. 2009. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med 361, 2252-2260.
111. Sudhir, K., Chou, T.M., Messina, L.M., Hutchison, S.J., Korach, K.S., Chatterjee, K. & Rubanyi, G.M. 1997. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 349, 1146-1147.
112. Sugioka, K., Shimosegawa, Y. & Nakano, M. 1987. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210, 37-39.
113. Takeda, K., Toda, K., Saibara, T., Nakagawa, M., Saika, K., Onishi, T., Sugiura, T. & Shizuta, Y. 2003. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176, 237-246.
114. Terasawa, E., Noel, S.D. & Keen, K.L. 2009. Rapid action of oestrogen in luteinising hormone-releasing hormone neurones: the role of GPR30. J Neuroendocrinol 21, 316-321.
115. Thomas, P., Pang, Y., Filardo, E.J. & Dong, J. 2005. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146, 624-632.
116. Van Gaal, L.F., Mertens, I.L. & De Block, C.E. 2006. Mechanisms linking obesity with cardiovascular disease. Nature 444, 875-880.
117. Vivacqua, A., Lappano, R., De Marco, P., Sisci, D., Aquila, S., De Amicis, F., Fuqua, S.A., Ando, S. & Maggiolini, M. 2009. G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. Mol Endocrinol 23, 1815-1826.
118. Wade, J. 2009. Estradiol can modulate sensory processing with rapid and longer term consequences. J Biosci 34, 345-347.
119. Walter, P., Green, S., Greene, G., Krust, A., Bornert, J.M., Jeltsch, J.M., Staub, A., Jensen, E., Scrace, G. & Waterfield, M. 1985. Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82, 7889-7893.
120. WHO 2000. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894, i-xii, 1-253.
121. Windahl, S.H., Andersson, N., Chagin, A.S., Martensson, U.E., Carlsten, H., Olde, B., Swanson, C., Moverare-Skrtic, S., Savendahl, L., Lagerquist, M.K., Leeb-Lundberg, L.M. & Ohlsson, C. 2009. The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am J Physiol Endocrinol Metab 296, E490-E496.
122. Wong, W.P., Tiano, J.P., Liu, S., Hewitt, S.C., Le May, C., Dalle, S., Katzenellenbogen, J.A., Katzenellenbogen, B.S., Korach, K.S. & Mauvais-Jarvis, F. 2010. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc Natl Acad Sci USA 107, 13057-13062.
123. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A. & Chen, H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830.
124. Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J. & Lisheng, L. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952.
125. Zitzmann, M. 2009. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 5, 673-681.